24 May 2013
Keywords: roche, pegasys, fares, well, vs, peg-ifn, alfa-2b
Article | 05 May 2008
Swiss drug major Roche says that new data from three studies indicate that chronic hepatitis C patients who received Pegasys ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 May 2008
2 June 2008
23 May 2013
© 2013 thepharmaletter.com